Cancer research is a crucial pillar for countries to deliver more affordable, higher quality,
and more equitable cancer care. Patients treated in research-active hospitals have better …

Objective The ongoing COVID-19 pandemic has caused an indefinite delay to cancer
screening programs worldwide. This study aims to explore the impact on breast cancer …

In this work, we present the combination of two different types of nanomaterials, 2D
molybdenum disulfide nanosheets (MoS2-NS) and zero-dimensional carbon nanodots …

We link data on regional Organized Screening Programs (OSPs) throughout Europe with
survey data and population-based cancer registries to estimate effects of OSPs on breast …

Introduction As the global burden of chronic cancer increases, its correlation to lifestyle,
socioeconomic status (SES) and health equity becomes more important. The aim of the …

Mammography screening has been shown to be able to reduce breast cancer mortality,
leading most European countries to implement mammography‐based screening …

Abstract Objective In France, the national breast cancer screening programme (NBCSP),
targeting women aged 50–74 years was rolled out nationwide in 2004. It aims at reducing …

Background Multiple studies over the past 4 decades have shown the significant benefit of
breast cancer screening (BCS) in reducing mortality rates from breast cancer (BC). However …

Background The benefits of mammographic screening have been shown to include a
decrease in mortality due to breast cancer. Taiwan's Breast Cancer Screening Program is a …

Ensuring equity in cancer screening is recommended by the European Commission.
Despite the fact that breast cancer screening is a free population-based program in Spain …